Ginseng ( DrugBank: Ginseng )

3 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	2
46	Malignant rheumatoid arthritis	1
53	Sjogren syndrome	1

13. Multiple sclerosis/Neuromyelitis optica

Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01712373 (ClinicalTrials.gov)	December 2010	19/10/2012	Ginseng in Treatment of Fatigue in Multiple Sclerosis	Study of Ginseng in Treatment of Fatigue in Multiple Sclerosis	Fatigue	Drug: Ginseng;Drug: Placebo	Isfahan University of Medical Sciences	NULL	Completed	18 Years	50 Years	Both	60	Phase 2	Iran, Islamic Republic of
2	NCT00754832 (ClinicalTrials.gov)	September 2005	16/9/2008	American Ginseng Treatment for Multiple Sclerosis Related Fatigue	A Double-blinded, Placebo-controlled Crossover Pilot Study of American Ginseng Treatment for Multiple Sclerosis Related Fatigue	Multiple Sclerosis	Drug: American ginseng extract HT-1001;Drug: placebo	Oregon Health and Science University	National Multiple Sclerosis Society	Completed	18 Years	70 Years	All	56	Phase 2	United States

Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1900026257	2019-09-28	2019-09-28	A Randomized, Double-Blind Clinical Trial for Effect of Wisconsin Ginseng (Panax quinquefolius) in Improvement of Rheumatoid Arthritis Associated Fatigue	Efficacy, dose comparison, and safety of Wisconsin Ginseng (Panax quinquefolius) in patients with rheumatoid arthritis associated fatigue: Three-arm parallel, multicenter, randomized, double-blind, placebo-controlled, phase 2 trial	Rheumatoid arthritis (RA)	High-dose experimental group :6000mg Wisconsin ginseng (Panax quinquefolius) herb intervention: 3000mg, orally, twice daily (bid) Capsule (6 capsules / 500mg) ;Low-dose experimental group:3000mg Wisconsin ginseng (Panax quinquefolius) herb intervention: 1500mg, orally, twice daily (bid) Capsule (3 capsules / 500mg); 3000mg Placebo: 1500mg, orally, twice daily (bid) Capsule (3 capsules / 500mg) ;Control group :6000mg Placebo: 3000mg, orally, twice daily (bid) Capsule (6 capsules / 500mg) ;	Zhejiang Provincal Hospital of TCM	NULL	Pending	18	70	Both	High-dose experimental group :30;Low-dose experimental group:30;Control group :30;	Phase 2	China

Clinical trials : 283 / Drugs : 320 - (DrugBank : 101) / Drug target genes : 56 - Drug target pathways : 181

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03983408 (ClinicalTrials.gov)	June 17, 2019	10/6/2019	Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease	Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease	Sjögren's Syndrome;Rheumatic Diseases;Korean Red Ginseng	Dietary Supplement: Korean Red Ginseng;Dietary Supplement: Placebo	Hanyang University	The Korean Society of Ginseng	Recruiting	19 Years	75 Years	All	120	N/A	Korea, Republic of